Showing results (111-120 of 173) with videos related to

Sort By:
Pageof 18
Journal of Immunology (Baltimore, Md. : 1950)|May 13, 2011
Docking of lytic granules at the immunological synapse in human CTL requires Vti1b-dependent pairing with CD3 endosomesBin Qu, Varsha Pattu, Christian Junker, et al.
Frontiers in Oncology|December 7, 2020
Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS LymphomaMoritz Bewarder, Maximilian Kiefer, Clara Moelle, et al.
ESC Heart Failure|May 11, 2018
Therapeutic implications of a combined diagnostic workup including endomyocardial biopsy in an all-comer population of patients with heart failure: a retrospective analysisEfthymios Sotiriou, Susanne Heiner, Thomas Jansen, et al.
Journal of Diabetes and Its Complications|April 24, 2012
Hyperglycemia and oxidative stress in cultured endothelial cells--a comparison of primary endothelial cells with an immortalized endothelial cell lineSusanne Karbach, Thomas Jansen, Sven Horke, et al.
International Journal of Cancer|March 3, 2004
Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitisBoris Kubuschok, Xiaoxiun Xie, Ralf Jesnowski, et al.
Oncogene|April 5, 2005
Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemiaRalf Kronenwett, Ulf Butterweck, Ulrich Steidl, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Active breathing control (ABC): determination and reduction of breathing-induced organ motion in the chestBernd Gagel, Cengiz Demirel, Aline Kientopf, et al.
Scientific Reports|April 26, 2024
Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomasMichelle Elbert, Frank Neumann, Maximilian Kiefer, et al.
Nature Cancer|January 6, 2026
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trialPaolo Strati, Lori Leslie, Parveen Shiraz, et al.
Oxidative Medicine and Cellular Longevity|January 29, 2019
The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular InflammationSebastian Steven, Matthias Oelze, Michael Hausding, et al.
Pageof 18